| Literature DB >> 25119036 |
Dorota Skowronska-Krawczyk1, Qi Ma1, Michal Schwartz2, Kathleen Scully1, Wenbo Li1, Zhijie Liu1, Havilah Taylor1, Jessica Tollkuhn1, Kenneth A Ohgi1, Dimple Notani1, Yoshinori Kohwi3, Terumi Kohwi-Shigematsu3, Michael G Rosenfeld1.
Abstract
Homeodomain proteins, described 30 years ago, exert essential roles in development as regulators of target gene expression; however, the molecular mechanisms underlying transcriptional activity of homeodomain factors remain poorly understood. Here investigation of a developmentally required POU-homeodomain transcription factor, Pit1 (also known as Pou1f1), has revealed that, unexpectedly, binding of Pit1-occupied enhancers to a nuclear matrin-3-rich network/architecture is a key event in effective activation of the Pit1-regulated enhancer/coding gene transcriptional program. Pit1 association with Satb1 (ref. 8) and β-catenin is required for this tethering event. A naturally occurring, dominant negative, point mutation in human PIT1(R271W), causing combined pituitary hormone deficiency, results in loss of Pit1 association with β-catenin and Satb1 and therefore the matrin-3-rich network, blocking Pit1-dependent enhancer/coding target gene activation. This defective activation can be rescued by artificial tethering of the mutant R271W Pit1 protein to the matrin-3 network, bypassing the pre-requisite association with β-catenin and Satb1 otherwise required. The matrin-3 network-tethered R271W Pit1 mutant, but not the untethered protein, restores Pit1-dependent activation of the enhancers and recruitment of co-activators, exemplified by p300, causing both enhancer RNA transcription and target gene activation. These studies have thus revealed an unanticipated homeodomain factor/β-catenin/Satb1-dependent localization of target gene regulatory enhancer regions to a subnuclear architectural structure that serves as an underlying mechanism by which an enhancer-bound homeodomain factor effectively activates developmental gene transcriptional programs.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25119036 PMCID: PMC4358797 DOI: 10.1038/nature13573
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962